| User's Publication |
|
21714
Mitsui A, Iioka H, Ling Y, Okuda S, Kurose A, Schopperle M, Kondo T, Sakaguchi M, Saito K, Kondo E.
Pathological and biological significance of the specific glycan, TRA-1-60, on aggressive gastric adenocarcinoma.
Lab Invest
2024
102073
PubMed ID: 38718982
DOI: 10.1016/j.labinv.2024.102073
|
|
22091
Kume K, Iida M, Iwaya T, Yashima-Abo A, Koizumi Y, Endo A, Wade K, Hiraki H, Calvert V, Wulfkuhle J, Espina V, Siwak DR, Lu Y, Takemoto K, Suzuki Y, Sasaki Y, Tokino T, Petricoin E 3rd, Liotta LA, Mills GB, Nishizuka SS.
Targeted dynamic phospho-proteogenomic analysis of gastric cancer cells suggests host immunity provides survival benefit.
Mol Cell Proteomics
2024
100870
PubMed ID: 39461475
DOI: 10.1016/j.mcpro.2024.100870
|
|
19612
Mao X, Wang J, Luo F.
α-Fetoprotein contributes to the malignant biological properties of AFP-producing gastric cancer
Open Life Sci
2023
18(1):20220476
PubMed ID: 37588998
DOI: 10.1515/biol-2022-0476
|
|
19687
Mori Y, Nishikawa SG, Fratiloiu AR, Tsutsui M, Kataoka H, Joh T, Johnston RN.
Modulation of Reoviral Cytolysis (I): Combination Therapeutics
Viruses
2023
15(7):1472
PubMed ID: 37515160
DOI: 10.3390/v15071472
|
|
19874
Safari M, Scotto L, Litman T, Petrukhin LA, Zhu H, Shen M, Robey RW, Hall MD, Fojo T, Bates SE.
Novel Therapeutic Strategies Exploiting the Unique Properties of Neuroendocrine Neoplasms
Cancers (Basel)
2023
15(20):4960
PubMed ID: 37894327
DOI: 10.3390/cancers15204960
|
|
21108
Yasumoto A, Fujimori H, Mochizuki M, Shibuya-Takahashi R, Nakamura-Shima M, Shindo N, Yamaguchi K, Fukushi D, Wakui Y, Sugai T, Iwai W, Abue M, Sato I, Satoh K, Katayose Y, Yasuda J, Shibata C, Tamai K.
BEX2 is poor prognostic factor and required for cancer stemness in gastric cancer.
Biochem Biophys Res Commun
2023
655:59-67
PubMed ID: 36933308
DOI: 10.1016/j.bbrc.2023.03.025
|
|
21415
Fukuoka S, Koga Y, Yamauchi M, Koganemaru S, Yasunaga M, Shitara K, Doi T, Yoshino T, Kuronita T, Elenbaas B, Wahra P, Zhang H, Crowley L, Jenkins MH, Clark A, Kojima T.
p70S6K/Akt dual inhibitor DIACC3010 is efficacious in preclinical models of gastric cancer alone and in combination with trastuzumab.
Sci Rep
2023
13(1):16017
PubMed ID: 37749105
DOI: 10.1038/s41598-023-40612-9
|
|
21420
Tsujio G, Yashiro M, Sakuma T, Aoyama R, Maruo K, Yamamoto Y, Maeda K.
Impact of SMAD2 and MET Expression on Lymph Node Metastasis of HER2-positive Gastric Cancer Cells.
Anticancer Res
2023
43(10):4359-4364
PubMed ID: 37772583
DOI: 10.21873/anticanres.16631
|
|
21459
Hori N, Tazawa H, Li Y, Okura T, Kikuchi S, Kuroda S, Ohara T, Noma K, Nishizaki M, Urata Y, Kagawa S, Fujiwara T.
Intraperitoneal Administration of p53-armed Oncolytic Adenovirus Inhibits Peritoneal Metastasis of Diffuse-type Gastric Cancer Cells.
Anticancer Res
2023
43(11):4809-4821
PubMed ID: 37909979
DOI: 10.21873/anticanres.16678
|
|
21477
Takeuchi C, Sato J, Yamamichi N, Kageyama-Yahara N, Sasaki A, Akahane T, Aoki R, Nakajima S, Ito M, Yamamichi M, Liu YY, Sakuma N, Takahashi Y, Sakaguchi Y, Tsuji Y, Sakurai K, Tomida S, Niimi K, Ushijima T, Fujishiro M.
Marked intestinal trans-differentiation by autoimmune gastritis along with ectopic pancreatic and pulmonary trans-differentiation.
J Gastroenterol
2023
PubMed ID: 37962678
DOI: 10.1007/s00535-023-02055-x
|
|
20619
Shirakihara T, Yamaguchi H, Kondo T, Yashiro M, Sakai R.
Transferrin receptor 1 promotes the fibroblast growth factor receptor-mediated oncogenic potential of diffused-type gastric cancer.
Oncogene
2022
PubMed ID: 35338344
DOI: 10.1038/s41388-022-02270-5
|
|
20642
Kasai S, Kuwayama N, Motoo Y, Kawashima A, Matsumoto K, Yano S, Matsushima K, Yasumoto K.
Dual blockade of MET and VEGFR2 signaling pathways as a potential therapeutic maneuver for peritoneal carcinomatosis in scirrhous gastric cancer.
Biochem Biophys Res Commun
2022
600:80-86
PubMed ID: 35196631
DOI: 10.1016/j.bbrc.2022.02.045
|
|
20664
Han Y, Dong Q, Liu T, Chen X, Yu C, Zhang Y.
The novel mechanism of Med12-mediated drug resistance in a TGFBR2-independent manner.
Biochem Biophys Res Commun
2022
610:1-7
PubMed ID: 35461070
DOI: 10.1016/j.bbrc.2022.04.029
|
|
20907
Sera T, Sakuma T, Maruo K, Tsujio G, Yamamoto Y, Sugimoto A, Kushiyama S, Togano S, Kuroda K, Kasashima H, Ohira M, Maeda K.
Candidate Oncogenes, ARHGAP4, NOS3, and OR51B5, for the Development of Scirrhous-type Gastric Cancer.
Anticancer Res
2022
42(11):5195-5203
PubMed ID: 36288877
DOI: 10.21873/anticanres.16026
|
|
13281
Kajioka H, Kagawa S, Ito A, Yoshimoto M, Sakamoto S, Kikuchi S, Kuroda S, Yoshida R, Umeda Y, Noma K, Tazawa H, Fujiwara T.
Targeting neutrophil extracellular traps with thrombomodulin prevents pancreatic cancer metastasis.
Cancer Lett
2021
PubMed ID: 33065249
DOI: 10.1016/j.canlet.2020.10.015
|
|
13337
Kim S, Ahn JM, Bae WJ, Han JH, Lee D.
Quantitation of ligand is critical for ligand-dependent MET signalling activation and determines MET-targeted therapeutic response in gastric cancer.
Gastric Cancer
2021
24(3):577-588
PubMed ID: 33164142
DOI: 10.1007/s10120-020-01139-4
|
|
20028
Ito A, Kagawa S, Sakamoto S, Kuwada K, Kajioka H, Yoshimoto M, Kikuchi S, Kuroda S, Yoshida R, Tazawa H, Fujiwara T.
Extracellular vesicles shed from gastric cancer mediate protumor macrophage differentiation.
BMC Cancer
2021
21(1):102
PubMed ID: 33509150
DOI: 10.1186/s12885-021-07816-6
|
|
20191
Matsumi Y, Kagawa T, Yano S, Tazawa H, Shigeyasu K, Takeda S, Ohara T, Aono H, Hoffman RM, Fujiwara T, Kishimoto H.
Hyperthermia generated by magnetic nanoparticles for effective treatment of disseminated peritoneal cancer in an orthotopic nude-mouse model.
Cell Cycle
2021
1-12
PubMed ID: 34110969
DOI: 10.1080/15384101.2021.1919441
|
|
20415
Ikari N, Serizawa A, Tanji E, Yamamoto M, Furukawa T.
Analysis of RHOA mutations and their significance in the proliferation and transcriptome of digestive tract cancer cells.
Oncol Lett
2021
22(4):735
PubMed ID: 34466148
DOI: 10.3892/ol.2021.12996
|
|
16129
Nagamura Y, Miyazaki M, Nagano Y, Tomiyama A, Ohki R, Yanagihara K, Sakai R, Yamaguchi H.
SHP2 as a Potential Therapeutic Target in Diffuse-Type Gastric Carcinoma Addicted to Receptor Tyrosine Kinase Signaling
Cancers (Basel)
2021
13(17):4309
PubMed ID: 34503119
DOI: 10.3390/cancers13174309
|
|
13504
Baatar S, Bai T, Yokobori T, Gombodorj N, Nakazawa N, Ubukata Y, Kimura A, Kogure N, Sano A, Sohda M, Sakai M, Tumenjargal A, Ogata K, Kuwano H, Shirabe K, Saeki H.
High RAD18 Expression is Associated with Disease Progression and Poor Prognosis in Patients with Gastric Cancer
Ann Surg Oncol
2020
27(11):4360-4368
PubMed ID: 32356270
DOI: 10.1245/s10434-020-08518-2
|
|
16827
Ishikawa W, Kikuchi S, Ogawa T, Tabuchi M, Tazawa H, Kuroda S, Noma K, Nishizaki M, Kagawa S, Urata Y, Fujiwara T.
Boosting Replication and Penetration of Oncolytic Adenovirus by Paclitaxel Eradicate Peritoneal Metastasis of Gastric Cancer
Mol Ther Oncolytics
2020
18:262-271
PubMed ID: 32728614
DOI: 10.1016/j.omto.2020.06.021
|
|
11505
Kageyama-Yahara N, Yamamichi N, Takahashi Y, Takeuchi C, Matsumoto Y, Sakaguchi Y, Koike K.
Tandem repeats of the 5' flanking region of human MUC5AC have a role as a novel enhancer in MUC5AC gene expression.
Biochem Biophys Rep
2019
18:100632
PubMed ID: 30993217
DOI: 10.1016/j.bbrep.2019.100632
|
|
11511
Behan FM, Iorio F, Picco G, Gonçalves E, Beaver CM, Migliardi G, Santos R, Rao Y, Sassi F, Pinnelli M, Ansari R, Harper S, Jackson DA, McRae R, Pooley R, Wilkinson P, van der Meer D, Dow D, Buser-Doepner C, Bertotti A, Trusolino L, Stronach EA, Saez-Rodriguez J, Yusa K, Garnett MJ.
Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens.
Nature
2019
PubMed ID: 30971826
DOI: 10.1038/s41586-019-1103-9
|
|
12415
Sakamoto S, Kagawa S, Kuwada K, Ito A, Kajioka H, Kakiuchi Y, Watanabe M, Kagawa T, Yoshida R, Kikuchi S, Kuroda S, Tazawa H, Fujiwara T.
Intraperitoneal cancer-immune microenvironment promotes peritoneal dissemination of gastric cancer
Oncoimmunology
2019
8(12):e1671760
PubMed ID: 31741772
DOI: 10.1080/2162402X.2019.1671760
|
|
14274
Chan EM, Shibue T, McFarland JM, Gaeta B, Ghandi M, Dumont N, Gonzalez A, McPartlan JS, Li T, Zhang Y, Bin Liu J, Lazaro JB, Gu P, Piett CG, Apffel A, Ali SO, Deasy R, Keskula P, Ng RWS, Roberts EA, Reznichenko E, Leung L, Alimova M, Schenone M, Islam M, Maruvka YE, Liu Y, Roper J, Raghavan S, Giannakis M, Tseng YY, Nagel ZD, D'Andrea A, Root DE, Boehm JS, Getz G, Chang S, Golub TR, Tsherniak A, Vazquez F, Bass AJ.
WRN helicase is a synthetic lethal target in microsatellite unstable cancers
Nature
2019
568(7753):551-556
PubMed ID: 30971823
DOI: 10.1038/s41586-019-1102-x
|
|
10662
Miyamoto S, Nagamura Y, Nakabo A, Okabe A, Yanagihara K, Fukami K, Sakai R, Yamaguchi H.
Aberrant alternative splicing of RHOA is associated with loss of its expression and activity in diffuse-type gastric carcinoma cells.
Biochem. Biophys. Res. Commun.
2018
495:1942-1947
PubMed ID: 29247652
DOI: 10.1016/j.bbrc.2017.12.067
|
|
4049
Taichi Yoshida, Takashi Maruyama, Masatomo Miura, Masahiro Inoue, Koji Fukuda, Kazuhiro Shimazu, Daiki Taguchi, Hiroaki Kanda, Masanobu Oshima, Yoshiharu Iwabuchi, Hiroyuki Shibata
Dietary intake of pyrolyzed deketene curcumin inhibits gastric carcinogenesis
Journal of Functional Foods
2018
50:192-200
DOI: 10.1016/j.jff.2018.09.033
|
|
4188
Suzuki M, Yokobori T, Gombodorj N, Yashiro M, Turtoi A, Handa T, Ogata K, Oyama T, Shirabe K, Kuwano H.
High stromal transforming growth factor β-induced expression is a novel marker of progression and poor prognosis in gastric cancer.
J Surg Oncol
2018
PubMed ID: 30260476
DOI: 10.1002/jso.25217
|
|
4380
Yoshioka T, Shien K, Namba K, Torigoe H, Sato H, Tomida S, Yamamoto H, Asano H, Soh J, Tsukuda K, Nagasaka T, Fujiwara T, Toyooka S.
Antitumor activity of pan-HER inhibitors in HER2-positive gastric cancer.
Cancer Sci.
2018
109(4):1166-1176
PubMed ID: 29465762
DOI: 10.1111/cas.13546
|
|
10277
Masuda T, Song W, Nakanishi H, Lei W, Noor AM, Arai F.
Rare cell isolation and recovery on open-channel microfluidic chip.
PLoS ONE
2017
12:e0174937
PubMed ID: 28426707
DOI: 10.1371/journal.pone.0174937
|
|
9594
Shibahara-Sone H, Gomi A, Iino T, Kano M, Nonaka C, Watanabe O, Miyazaki K, Ohkusa T.
Living cells of probiotic Bifidobacterium bifidum YIT 10347 detected on gastric mucosa in humans.
Benef Microbes
2016
7:319-26
PubMed ID: 26925600
DOI: 10.3920/BM2015.0138
|
|
9928
Diaz-Lagares A, Crujeiras AB, Lopez-Serra P, Soler M, Setien F, Goyal A, Sandoval J, Hashimoto Y, Martinez-Cardús A, Gomez A, Heyn H, Moutinho C, Espada J, Vidal A, Paúles M, Galán M, Sala N, Akiyama Y, Martínez-Iniesta M, Farré L, Villanueva A, Gross M, Diederichs S, Guil S, Esteller M.
Epigenetic inactivation of the p53-induced long noncoding RNA TP53 target 1 in human cancer.
Proc. Natl. Acad. Sci. U.S.A.
2016
113:E7535-E7544
PubMed ID: 27821766
DOI: 10.1073/pnas.1608585113
|
|
3733
Nishikawaji T, Akiyama Y, Shimada S, Kojima K, Kawano T, Eishi Y, Yuasa Y, Tanaka S.
Oncogenic roles of the SETDB2 histone methyltransferase in gastric cancer.
Oncotarget
2016
7(41):67251-67265
PubMed ID: 27572307
DOI: 10.18632/oncotarget.11625
|
|
5811
Maejima R et al
Enhanced expression of semaphorin 3E is involved in the gastric cancer development.
Int J Oncol
2016
49(3):887-94
PubMed ID: 27572291
DOI: 10.3892/ijo.2016.3593
|
|
5812
Hirashita Y et al
Reduced phosphorylation of ribosomal protein S6 is associated with sensitivity to MEK inhibition in gastric cancer cells.
Cancer Sci
2016
107(12):1919-1928
PubMed ID: 27699948
DOI: 10.1111/cas.13094
|
|
12639
Yamashita K, Kuno A, Matsuda A, Ikehata Y, Katada N, Hirabayashi J, Narimatsu H, Watanabe M.
Lectin microarray technology identifies specific lectins related to lymph node metastasis of advanced gastric cancer
Gastric Cancer
2016
19(2):531-54
PubMed ID: 25840959
DOI: 10.1007/s10120-015-0491-2
|
|
7357
Yamamoto S, Fei J, Okochi M, Shimizu K, Yusa A, Kondo N, Iwata H, Nakanishi H, Honda H.
Efficient capturing of circulating tumor cells using a magnetic capture column and a size-selective filter.
Bioprocess Biosyst Eng
2015
38:1693-704
PubMed ID: 25964183
DOI: 10.1007/s00449-015-1412-9
|
|
14977
Suenaga M, Yamada S, Fuchs BC, Fujii T, Kanda M, Tanaka C, Kobayashi D, Fujiwara M, Tanabe KK, Kodera Y.
CD44 single nucleotide polymorphism and isoform switching may predict gastric cancer recurrence
J Surg Oncol
2015
112(6):622-8
PubMed ID: 26416034
DOI: 10.1002/jso.24056
|
|
15000
Sakamoto A, Akiyama Y, Shimada S, Zhu WG, Yuasa Y, Tanaka S.
DNA Methylation in the Exon 1 Region and Complex Regulation of Twist1 Expression in Gastric Cancer Cells
PLoS One
2015
10(12):e0145630
PubMed ID: 26695186
DOI: 10.1371/journal.pone.0145630
|
|
15183
Toda K, Nagasaka T, Umeda Y, Tanaka T, Kawai T, Fuji T, Taniguchi F, Yasui K, Kubota N, Takehara Y, Tazawa H, Kagawa S, Sun DS, Nishida N, Goel A, Fujiwara T.
Genetic and epigenetic alterations of netrin-1 receptors in gastric cancer with chromosomal instability
Clin Epigenetics
2015
7(1):73
PubMed ID: 26207151
DOI: 10.1186/s13148-015-0096-y
|
|
18949
Murai T, Yamada S, Fuchs BC, Fujii T, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Tanabe KK, Kodera Y.
Epithelial-to-mesenchymal transition predicts prognosis in clinical gastric cancer
J Surg Oncol
2014
109(7):684-9
PubMed ID: 24453058
DOI: 10.1002/jso.23564
|
|
5825
Ito A, Ito Y, Matsushima S, Tsuchida D, Ogasawara M, Hasegawa J, Misawa K, Kondo E, Kaneda N, Nakanishi H.
New whole-body multimodality imaging of gastric cancer peritoneal metastasis combining fluorescence imaging with ICG-labeled antibody and MRI in mice.
Gastric Cancer
2014
17(3):497-507
PubMed ID: 24288123
DOI: 10.1007/s10120-013-0316-0
|
|
5302
Yamaguchi H, Takanashi M, Yoshida N, Ito Y, Kamata R, Fukami K, Yanagihara K, Sakai R.
Saracatinib impairs the peritoneal dissemination of diffuse-type gastric carcinoma cells resistant to Met and fibroblast growth factor receptor inhibitors.
Cancer Sci
2014
105(5):528-36
PubMed ID: 24612061
DOI: 10.1111/cas.12387
|
|
15817
Endo F, Nishizuka SS, Kume K, Ishida K, Katagiri H, Ishida K, Sato K, Iwaya T, Koeda K, Wakabayashi G.
A compensatory role of NF-κB to p53 in response to 5-FU-based chemotherapy for gastric cancer cell lines
PLoS One
2014
9(2):e90155
PubMed ID: 24587255
DOI: 10.1371/journal.pone.0090155
|
|
15987
Sogabe M, Nozaki H, Tanaka N, Kubota T, Kaji H, Kuno A, Togayachi A, Gotoh M, Nakanishi H, Nakanishi T, Mikami M, Suzuki N, Kiguchi K, Ikehara Y, Narimatsu H.
Novel glycobiomarker for ovarian cancer that detects clear cell carcinoma
J Proteome Res
2014
13(3):1624-35
PubMed ID: 24498956
DOI: 10.1021/pr401109n
|
|
5845
Konno-Shimizu M1, Yamamichi N, Inada K, Kageyama-Yahara N, Shiogama K, Takahashi Y, Asada-Hirayama I, Yamamichi-Nishina M, Nakayama C, Ono S, Kodashima S, Fujishiro M, Tsutsumi Y, Ichinose M, Koike K.
Cathepsin E is a marker of gastric differentiation and signet-ring cell carcinoma of stomach: a novel suggestion on gastric tumorigenesis.
PLoS One
2013
8(2):e56766
PubMed ID: 23451082
DOI: 10.1371/journal.pone.0056766
|
|
5847
Zhao L, Yasumoto K, Kawashima A, Nakagawa T, Takeuchi S, Yamada T, Matsumoto K, Yonekura K, Yoshie O, Yano S.
Paracrine activation of MET promotes peritoneal carcinomatosis in scirrhous gastric cancer.
Cancer Sci
2013
104(12):1640-6
PubMed ID: 24118504
DOI: 10.1111/cas.12301
|
|
6075
Murakami H, Nakanishi H, Tanaka H, Ito S, Misawa K, Ito Y, Ikehara Y, Kondo E, Kodera Y.
Establishment and characterization of novel gastric signet-ring cell and non signet-ring cell poorly differentiated adenocarcinoma cell lines with low and high malignant potential.
Gastric Cancer
2013
16(1):74-83
PubMed ID: 22450770
DOI: 10.1007/s10120-012-0149-2
|
|
13662
Murakami H, Ito S, Tanaka H, Kondo E, Kodera Y, Nakanishi H.
Establishment of new intraperitoneal paclitaxel-resistant gastric cancer cell lines and comprehensive gene expression analysis
Anticancer Res
2013
33(10):4299-307
PubMed ID: 24122996
|
|
18246
Enhancement of metastatic ability by ectopic expression of ST6GalNAcI on a gastric cancer cell line in a mouse model
Enhancement of metastatic ability by ectopic expression of ST6GalNAcI on a gastric cancer cell line in a mouse model
Clin Exp Metastasis
2012
29(3):229-38
PubMed ID: 22228572
DOI: 10.1007/s10585-011-9445-1
|
|
5853
Nakanishi H, Ito S, Matsui M, Ito Y, Misawa K, Kodera Y.
Noninvasive and real-time fluorescence imaging of peritoneal metastasis in nude mice.
Methods Mol Biol
2012
872:85-95
PubMed ID: 22700405
DOI: 10.1007/978-1-61779-797-2_6
|
|
5856
Sato Y, Morimoto K, Kubo T, Yanagihara K, Seyama T.
High mannose-binding antiviral lectin PFL from Pseudomonas fluorescens Pf0-1 promotes cell death of gastric cancer cell MKN28 via interaction with α2-integrin.
PLoS One
2012
7(9):e45922
PubMed ID: 23029318
DOI: 10.1371/journal.pone.0045922
|
|
16307
Ooki A, Yamashita K, Kikuchi S, Sakuramoto S, Katada N, Waraya M, Kawamata H, Nishimiya H, Nakamura K, Watanabe M.
Therapeutic potential of PRL-3 targeting and clinical significance of PRL-3 genomic amplification in gastric cancer
BMC Cancer
2011
11:122
PubMed ID: 21466710
DOI: 10.1186/1471-2407-11-122
|
|
8118
Shirasawa Y, Shibahara-Sone H, Iino T, Ishikawa F.
Bifidobacterium bifidum BF-1 suppresses Helicobacter pylori-induced genes in human epithelial cells.
J. Dairy Sci.
2010
93:4526-34
PubMed ID: 20854986
DOI: 10.3168/jds.2010-3274
|
|
6410
Danjoh I, Sone H, Noda N, Iimura E, Nagayoshi M, Saijo K, Hiroyama T, Nakamura Y.
Is parainfluenza virus a threatening virus for human cancer cell lines?
Hum Cell
2009
22(3):81-4
PubMed ID: 19624309
DOI: 10.1111/j.1749-0774.2009.00071.x
|
|
5893
Hara M, Nakanishi H, Jun Q, Kanemitsu Y, Ito S, Mochizuki Y, Yamamura Y, Kodera Y, Tatematsu M, Hirai T, Kato T.
Comparative analysis of intraperitoneal minimal free cancer cells between colorectal and gastric cancer patients using quantitative RT-PCR: possible reason for rare peritoneal recurrence in colorectal cancer.
Clin Exp Metastasis
2007
24(3):179-89
PubMed ID: 17487561
DOI: 10.1007/s10585-007-9067-9
|
|
18448
Yamashita H, Kitayama J, Shida D, Yamaguchi H, Mori K, Osada M, Aoki S, Yatomi Y, Takuwa Y, Nagawa H.
Sphingosine 1-phosphate receptor expression profile in human gastric cancer cells: differential regulation on the migration and proliferation
J Surg Res
2006
130(1):80-7
PubMed ID: 16183075
DOI: 10.1016/j.jss.2005.08.004
|
|
5899
Yokoyama H, Ikehara Y, Kodera Y, Ikehara S, Yatabe Y, Mochizuki Y, Koike M, Fujiwara M, Nakao A, Tatematsu M, Nakanishi H.
Molecular basis for sensitivity and acquired resistance to gefitinib in HER2-overexpressing human gastric cancer cell lines derived from liver metastasis.
Br J Cancer
2006
95(11):1504-13
PubMed ID: 17088902
DOI: 10.1038/sj.bjc.6603459
|
|
5906
Imura K, Ueda Y, Hayashi T, Itoh T, Shimizu K, Tamai H, Yano Y, Naito K, Kohara J, Nakane K, Matsuura Y, Takeda A, Takeda T, Kawai K, Yamagishi H.
Induction of cytotoxic T lymphocytes against human cancer cell lines using dendritic cell-tumor cell hybrids generated by a newly developed electrofusion technique.
Int J Oncol
2006
29(3):531-9
PubMed ID: 16865268
|
|
3077
Nakatsu N, Yoshida Y, Yamazaki K, Nakamura T, Dan S, Fukui Y, Yamori T
Chemosensitivity profile of cancer cell lines and identification of genes determining chemosensitivity by an integrated bioinformatical approach using cDNA arrays.
Mol Cancer Ther
2005
4:399-412
PubMed ID: 15767549
DOI: 10.1158/1535-7163.MCT-04-0234
|
|
5910
Nakanishi H, Ito S, Mochizuki Y, Tatematsu M.
Evaluation of chemosensitivity of micrometastases with green fluorescent protein gene-tagged tumor models in mice.
Methods Mol Med
2005
2005;111:351-62
PubMed ID: 15911990
DOI: 10.1385/1-59259-889-7:351
|
|
2807
Shida D, Kitayama J, Yamaguchi H, Hama K, Aoki J, Arai H, Yamashita H, Mori K, Sako A, Konishi T, Watanabe T, Sakai T, Suzuki R, Ohta H, Takuwa Y, Nagawa H
Dual mode regulation of migration by lysophosphatidic acid in human gastric cancer cells.
Exp Cell Res
2004
301:168-78
PubMed ID: 15530853
DOI: 10.1016/j.yexcr.2004.08.008
|
|
5397
Mochizuki Y, Nakanishi H, Kodera Y, Ito S, Yamamura Y, Kato T, Hibi K, Akiyama S, Nakao A, Tatematsu M.
TNF-alpha promotes progression of peritoneal metastasis as demonstrated using a green fluorescence protein (GFP)-tagged human gastric cancer cell line.
Clin Exp Metastasis
2004
21(1):39-47.
PubMed ID: 15065601
DOI: 10.1023/b:clin.0000017181.01474.35
|
|
18968
Akiyama Y, Maesawa C, Ogasawara S, Terashima M, Masuda T.
Cell-type-specific repression of the maspin gene is disrupted frequently by demethylation at the promoter region in gastric intestinal metaplasia and cancer cells
Am J Pathol
2003
163(5):1911-9
PubMed ID: 14578190
DOI: 10.1016/S0002-9440(10)63549-3
|
|
3796
Fukami T, Fukuhara H, Kuramochi M, Maruyama T, Isogai K, Sakamoto M, Takamoto S, Murakami Y.
Promoter methylation of the TSLC1 gene in advanced lung tumors and various cancer cell lines.
Int J Cancer
2003
107(1):53-9
PubMed ID: 12925956
DOI: 10.1002/ijc.11348
|
|
5931
Terashima M, Fujiwara H, Takagane A, Abe K, Irinoda T, Nakaya T, Yonezawa H, Oyama K, Saito K, Kanzaki N, Ohtani S, Nemoto T, Hoshino Y, Kogure M, Gotoh M.
Prediction of sensitivity to fluoropyrimidines by metabolic and target enzyme activities in gastric cancer.
Gastric Cancer
2003
6 Suppl 1:71-81.
PubMed ID: 12775024
DOI: 10.1007/s10120-003-0221-z
|
|
5932
Fujiwara 1, Terashima M, Irinoda T, Takagane A, Abe K, Nakaya T, Yonezawa H, Oyama K, Takahashi M, Saito K, Takechi T, Fukushima M, Shirasaka T.
Superior antitumour activity of S-1 in tumours with a high dihydropyrimidine dehydrogenase activity.
Eur J Cancer
2003
39(16):2387-94
PubMed ID: 14556932
DOI: 10.1016/s0959-8049(03)00513-6
|
|
5935
Dan S, Shirakawa M, Mukai Y, Yoshida Y, Yamazaki K, Kawaguchi T, Matsuura M, Nakamura Y, Yamori T.
Identification of candidate predictive markers of anticancer drug sensitivity using a panel of human cancer cell lines.
Cancer Sci
2003
94(12):1074-82
PubMed ID: 14662023
DOI: 10.1111/j.1349-7006.2003.tb01403.x
|
|
5941
Fujiwara H, Terashima M, Irinoda T, Takagane A, Abe K, Kashiwaba M, Oyama K, Takahashi M, Maesawa C, Saito K, Takechi T, Fukushima M.
Quantitative measurement of thymidylate synthase and dihydropyrimidine dehydrogenase mRNA level in gastric cancer by real-time RT-PCR.
Jpn J Cancer Res
2002
93(12):1342-50
PubMed ID: 12495474
DOI: 10.1111/j.1349-7006.2002.tb01243.x
|
|
19063
Bai Y, Akiyama Y, Nagasaki H, Yagi OK, Kikuchi Y, Saito N, Takeshita K, Iwai T, Yuasa Y.
Distinct expression of CDX2 and GATA4/5, development-related genes, in human gastric cancer cell lines
Mol Carcinog
2000
28(3):184-8
PubMed ID: 10942535
DOI: 10.1002/1098-2744(200007)28:3<184::aid-mc7>3.0.co;2-6
|
|
3763
Takaishi S, Sawada M, Morita Y, Seno H, Fukuzawa H, Chiba T.
Identification of a novel alternative splicing of human FGF receptor 4: soluble-form splice variant expressed in human gastrointestinal epithelial cells.
Biochem Biophys Res Commun
2000
19;267(2):658-62
PubMed ID: 10631118
DOI: 10.1006/bbrc.1999.2010
|
|
1906
Iida S, Akiyama Y, Nakajima T, Ichikawa W, Nihei Z, Sugihara K, Yuasa Y.
Alterations and hypermethylation of the p14(ARF) gene in gastric cancer
Int J Cancer
2000
87(5):654-8
PubMed ID: 10925358
DOI: 10.1002/1097-0215(20000901)87:5<654::aid-ijc6>3.0.co;2-p
|
|
6386
Oji Y, Ogawa H, Tamaki H, Oka Y, Tsuboi A, Kim EH, Soma T, Tatekawa T, Kawakami M, Asada M, Kishimoto T, Sugiyama H.
Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth.
Jpn J Cancer Res
1999
90(2):194-204
PubMed ID: 10189890
DOI: 10.1111/j.1349-7006.1999.tb00733.x
|
|
17255
Saijo Y, Hong X, Tanaka M, Tazawa R, Liu SQ, Saijo K, Ohno T, Koike K, Ohkuda K, Satoh K, Nukiwa T.
Autologous high-killing cytotoxic T lymphocytes against human lung cancer are induced using interleukin (IL)-1beta, IL-2, IL-4, and IL-6: possible involvement of dendritic cells
Clin Cancer Res
1999
5(5):1203-9
PubMed ID: 10353758
|
|
6409
Hassan S, Kinoshita Y, Kawanami C, Kishi K, Matsushima Y, Ohashi A, Funasaka Y, Okada A, Maekawa T, He-Yao W, Chiba T.
Expression of protooncogene c-kit and its ligand stem cell factor (SCF) in gastric carcinoma cell lines.
Dig Dis Sci
1998
43(1):8-14
PubMed ID: 9508539
DOI: 10.1023/a:1018851415704
|
|
5973
Tamura G, Sakata K, Nishizuka S, Maesawa C, Suzuki Y, Iwaya T, Terashima M, Saito K, Satodate R.
Analysis of the fragile histidine triad gene in primary gastric carcinomas and gastric carcinoma cell lines.
Genes Chromosomes Cancer
1997
20(1):98-102
PubMed ID: 9290961
|
|
2062
Wang, D S, Ueno Y, Oyamada H, Kojima S
Accumulation of NCC-CO-411 monoclonal antibody in human colorectal adenocarcinoma through binding of the released carcinoembryonic antigen in nude mice.
Biol Pharm Bull
1996
19:915-21
PubMed ID: 8839961
DOI: 10.1248/bpb.19.915
|
|
2177
Tamura G, Sakata K, Nishizuka S, Maesawa C, Suzuki Y, Iwaya T, Terashima M, Saito K, Satodate R
Inactivation of the E-cadherin gene in primary gastric carcinomas and gastric carcinoma cell lines
Jpn J Cancer Res
1996
87:1153-1159
PubMed ID: 9045944
DOI: 10.1111/j.1349-7006.1996.tb03125.x
|
|
2063
Wang, D., S., Ueno, Y., Oyamada, H., and Kojima, S.
Radioimmunoimaging of Human Colorectal Adenocarcinoma with a Monoclonal Antibody, NCC-CO-411, Against a Human Carcinoembryonic Antigen
Antibody, Immunoconjugates, and Radiopharmaceuticals
1995
8:129-143
|
|
6407
Matsushima Y, Kinoshita Y, Nakata H, Inomoto-Naribayashi Y, Asahara M, Kawanami C, Nakamura A, Ito M, Matsui T, Fujiwara T, et al.
Gastrin receptor gene expression in several human carcinomas.
Jpn J Cancer Res
1994
85(8):819-24
PubMed ID: 7928627
DOI: 10.1111/j.1349-7006.1994.tb02953.x
|
Back
Top
CELL BANK Website